Nausea and vomiting that can be caused by many conditions. Common causes include motion sickness, self-limited illnesses that last a few hours to a few days, and toxins. Antiemetics drugs are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics and chemotherapy directed against cancer. Various types of antiemetics can decrease the severity of nausea, although most require a medical evaluation and prescription.
Request Sample Report @ http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=52728
Increasing incidences of various types of cancer along with the side effects of chemotherapy is major key factor of antiemetic drugs market. Additionally, increasing prevalence of lifestyle induced diseases expected to boost demand for antiemetic drugs during the forecast period. Moreover, introduction technologically advanced drug delivery and rising awareness regarding clinical benefits anticipated to grow significantly during the forecast period. However, lack of suitable animal model to imitate the human responses to antiemetic therapy hampers the market growth.
The antiemetic drug market is segmented on the basis of type, application and geography. On the basis of class is segmented into as 5-HT3 receptor antagonists, dopamine antagonists, NK1 receptor antagonist, antihistamines, cannabinoids and others. 5-HT3 antagonist segment expected to witness significant growth over the forecast period. On the basis of application, the market has been segmented into chemotherapy, motion sickness, gastroenteritis, general anesthetics, opioid analgesics, dizziness, pregnancy, food poisoning, emotional stress and others. Chemotherapy is leading application segment of antiemetic drug market.
Purchase a direct copy of report with TOC @ http://www.syndicatemarketresearch.com/market-analysis/antiemetic-drug-market.html#table-of-content
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil. North America and Europe are dominated regions for antiemetic drug market. With increasing population and incidences of gastroenteritis diseases in the Asia Pacific region has boost up the demand for antiemetic drug and expected to fuel market growth in this region.
The report covers forecast and analysis for the antiemetic drug market on a global and regional level. The report provides comprehensive view on the antiemetic drug market, study included a detailed competitive scenario and product portfolio of key vendors. The report analyzes the attractiveness of segments. Additionally, the study analyzes market competition and industry players using Porter’s five forces analysis.
Browse the full report @ http://www.syndicatemarketresearch.com/market-analysis/antiemetic-drug-market.html
Some of the key players operating in antiemetic drug market include Pfizer, GlaxoSmithCline, Merck, Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly and Company, Astellas Pharma, Johnson & Johnson and Baxter International
This report segments the global antiemetic drug market as follows:
Antiemetic Drug Market: Type Segment Analysis
- 5-HT3 Receptor Antagonists
- Dopamine Antagonists
- NK1 Receptor Antagonist
Antiemetic Drug Market: Application Segment Analysis
- Motion Sickness
- General Anesthetics
- Opioid Analgesics
- Food Poisoning
- Emotional Stress
Antiemetic Drug Market: Regional Segment Analysis
- North America
- Asia Pacific
- Latin America
- Middle East & Africa